Is Oral Lipid-Based Delivery for Drug Targeting to the Brain Feasible?
This review outlines the feasibility of oral lipid-based targeted delivery of drugs to the brain, including permeation of the central nervous system’s (CNS) protective blood-brain barrier (BBB). The structure of the BBB and disruption caused by varying disease states highlights the need for disease-specific approaches to alter permeation. Disruption during disease state, and the effects of certain molecules on the barrier, demonstrate the possibility of exploiting such BBB disruption for drug delivery.
Highlights
Blood brain barrier permeability can be influenced by certain lipids (oleic acid, triolein, alkylglycerols)
The required plasma concentration of lipids to alter the blood brain barrier could be reached.
Oral lipid-based drug delivery to the brain could be feasible in theory, but more data are needed.
Many administration methods can be used to target the brain, but oral administration is considered ideal for chronic, long-term illnesses. Several lipids that have been shown to facilitate drug delivery into the brain after systemic administration, but could also be delivered orally are discussed, including oleic acid, triolein, alkylglycerol, and conjugates of linoleic and myristic acids. Current data reveal the potential for the use of such lipids as part of oral formulations for delivery to the brain by reaching sufficient plasma levels after administration to increase the permeability of the BBB. However, gaps in the literature remain regarding the concentrations and form of most lipids required to produce the desired effects.
The use of lipids via oral delivery for brain targeting has not been investigated thoroughly enough to determine with certainty if similar permeability-enhancing effects would be observed as for parenteral administration. In conclusion, further research to fill research gaps is needed, but the limited evidence suggests that oral lipid-based drug delivery for brain targeting is potentially feasible.
Article information: Alice Brookes, Liuhang Ji, Tracey D. Bradshaw, Michael Stocks, David Gray, James Butler, Pavel Gershkovich, Is Oral Lipid-Based Delivery for Drug Targeting to the Brain Feasible?, European Journal of Pharmaceutics and Biopharmaceutics, 2022. https://doi.org/10.1016/j.ejpb.2022.02.004.